Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizhou Zhang

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Virology|September 24, 2025
Variation in virion phosphatidylserine content drives differential GAS6 binding among closely related flavivirusesLizhou Zhang, Byoung-Shik Shim, Claire Kitzmiller, et al.
Biorxiv : the Preprint Server for Biology|June 27, 2020
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivityLizhou Zhang, Cody B Jackson, Huihui Mou, et al.
Vaccine|February 4, 2014
A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virusXiaole Qi, Yuming Chen, Xiangang Ren, et al.
Plos One|August 8, 2013
Mutations of residues 249 and 256 in VP2 are involved in the replication and virulence of infectious Bursal disease virusXiaole Qi, Lizhou Zhang, Yuming Chen, et al.
Virus Research|July 30, 2015
Binding chicken Anx2 is beneficial for infection with infectious bursal disease virusXiangang Ren, Lizhou Zhang, Yulong Gao, et al.
Virus Research|April 15, 2015
Naturally occurring reassortant infectious bursal disease virus in northern ChinaZhen Lu, Lizhou Zhang, Nian Wang, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 19, 2024
Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitorsYuka Otsuka, Lizhou Zhang, Huihui Mou, et al.
Nature Biomedical Engineering|March 15, 2024
In vivo affinity maturation of mouse B cells reprogrammed to express human antibodiesYiming Yin, Yan Guo, Yuxuan Jiang, et al.
NPJ Vaccines|October 11, 2023
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stabilityLizhou Zhang, Kunal R More, Amrita Ojha, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
<i>In vivo</i> affinity maturation of murine B cells reprogrammed to express human antibodiesYiming Yin, Yan Guo, Yuxuan Jiang, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Virology|September 24, 2025
Variation in virion phosphatidylserine content drives differential GAS6 binding among closely related flavivirusesLizhou Zhang, Byoung-Shik Shim, Claire Kitzmiller, et al.
Biorxiv : the Preprint Server for Biology|June 27, 2020
The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivityLizhou Zhang, Cody B Jackson, Huihui Mou, et al.
Vaccine|February 4, 2014
A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virusXiaole Qi, Yuming Chen, Xiangang Ren, et al.
Plos One|August 8, 2013
Mutations of residues 249 and 256 in VP2 are involved in the replication and virulence of infectious Bursal disease virusXiaole Qi, Lizhou Zhang, Yuming Chen, et al.
Virus Research|July 30, 2015
Binding chicken Anx2 is beneficial for infection with infectious bursal disease virusXiangang Ren, Lizhou Zhang, Yulong Gao, et al.
Virus Research|April 15, 2015
Naturally occurring reassortant infectious bursal disease virus in northern ChinaZhen Lu, Lizhou Zhang, Nian Wang, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 19, 2024
Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitorsYuka Otsuka, Lizhou Zhang, Huihui Mou, et al.
Nature Biomedical Engineering|March 15, 2024
In vivo affinity maturation of mouse B cells reprogrammed to express human antibodiesYiming Yin, Yan Guo, Yuxuan Jiang, et al.
NPJ Vaccines|October 11, 2023
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stabilityLizhou Zhang, Kunal R More, Amrita Ojha, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
<i>In vivo</i> affinity maturation of murine B cells reprogrammed to express human antibodiesYiming Yin, Yan Guo, Yuxuan Jiang, et al.
Pageof 4